Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

DYNDYN
Showing 8 of 24 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in DYNE THERAPEUTICS INC

CITADEL ADVISORS LLC holds 1.1M shares of DYN (DYNE THERAPEUTICS INC), worth $25.4M as of 2026-Q2. The position was increased (+468.7% shares). DYN represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$25.4M

Current Shares

1.1M

Total Value Change

-$80.2M

Total Shares Change

-1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+468.7%
$25.4M0.0%$22.21
46
2026-Q1
Decreased
201,144
-82.8%
$3.6M0.0%$14.60
0
2025-Q4
Decreased
1.2M
-65.7%
$22.9M0.0%$19.20
0
2025-Q3
Increased
3.4M
+261.6%
$43.2M0.0%$12.37
47
2025-Q2
Decreased
943,874
-68.6%
$9M0.0%$9.57
0
2025-Q1
Increased
3M
+5.2%
$31.5M0.0%$11.45
30
2024-Q4
Decreased
2.9M
-2.6%
$67.4M0.0%$23.65
0
2024-Q3
Decreased
2.9M
-31.9%
$105.6M0.0%$33.83
0

Other major holders of DYN: BlackRock, Inc., Janus Henderson Group Ltd., BlackRock Finance, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used